日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes

在实验性脓毒症期间,以HMGB1为靶点的治疗可以调节炎症细胞因子谱,使其与改善临床结局相关。

Stevens, Natalie E; Chapman, Marianne J; Fraser, Cara K; Kuchel, Tim R; Hayball, John D; Diener, Kerrilyn R

Preserved antiviral adaptive immunity following polyclonal antibody immunotherapy for severe murine influenza infection.

多克隆抗体免疫疗法治疗严重鼠流感感染后,抗病毒适应性免疫得以保留

Stevens Natalie E, Hatjopolous Antoinette, Fraser Cara K, Alsharifi Mohammed, Diener Kerrilyn R, Hayball John D

Induction of both cellular and humoral immunity following a rational prime-boost immunization regimen that incorporates recombinant ovine atadenovirus and fowlpox virus

采用包含重组绵羊腺病毒和禽痘病毒的合理初免-加强免疫方案,可诱导细胞免疫和体液免疫。

Fraser, Cara K; Diener, Kerrilyn R; Lousberg, Erin L; Both, Gerald W; Ward, Larry; Brown, Michael P; Hayball, John D